Sinopharm Covid-19 Vaccine Is Now Available In Malaysia

Duopharma Biotech Bhd is further strengthening COVID-19 vaccination efforts in Malaysia with the distribution of the Sinopharm COVID-19 vaccine. Earlier, Duopharma Biotech had entered into an agreement to import the vaccine from Beijing, China, covering a collaboration for the Malaysian market.

“The challenge in overcoming the COVID-19 pandemic requires collaboration and coordination at all levels. Duopharma Biotech is committed to supporting the Government’s vaccination programme and augmenting the National COVID-19 Immunisation Programme, by expanding vaccine distribution channels to ensure full vaccine coverage in Malaysia,” said Leonard Ariff Abdul Shatar, Group Managing Director of Duopharma Biotech.

Efficient administration process
The first shipments of the Sinopharm vaccine arrived in Malaysia in batches in September, and is now widely available at clinics and private hospitals nationwide. With a shelf life of 24 months, it is appropriate for longer term vaccination efforts. Additionally, the Sinopharm vaccine is a convenient single dose per vial of 0.5mL, which helps to prevent wastage and is easy for planning vaccine administration. The vaccine’s cold chain storage is also straightforward and easy, at a standard conventional storage temperature of 2°C to 8°C. 

Administration of the vaccine is fully integrated into the national immunisation system, where the vaccines are tracked based on the Vaccine Management System provided by the Ministry of Health, with real-time integration of both MyVAS and the MySejahtera app. Vaccinees receiving their first and second doses will immediately have these recorded on their MySejahtera accounts, and will also receive their digital certificate accordingly.

For vaccination of large groups, such as the workforce in manufacturing facilities, Duopharma Biotech, via collaboration with healthcare organisers, provides private vaccination services as well as mobile vaccine clinics, which is supported by a team of medical professionals, paramedics, site managers and an operations and administration team. 
Healthcare providers interested to procure the Sinopharm vaccine or corporations wishing to arrange for vaccination may contact Duopharma Biotech’s Customer Service for enquiries via email at [email protected].

Previous articleHOC’s Implementation May Be Prolonged
Next article12MP To Promote Cataclictic Growth For The Malaysian Aerospace Industry


Please enter your comment!
Please enter your name here